Tenaya Therapeutics, Inc.
TNYA
$0.89
$0.033.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.18M | -20.28M | -23.28M | -26.86M | -23.84M |
| Total Depreciation and Amortization | 1.83M | 1.86M | 2.08M | 2.66M | 2.09M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.52M | 3.73M | 4.58M | 4.53M | 4.40M |
| Change in Net Operating Assets | 893.00K | -921.00K | 1.01M | -3.44M | -1.04M |
| Cash from Operations | -13.94M | -15.60M | -15.61M | -23.11M | -18.39M |
| Capital Expenditure | -67.00K | -26.00K | -142.00K | -383.00K | -204.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 8.89M | 25.13M | 22.69M | 14.31M |
| Cash from Investing | -67.00K | 8.86M | 24.99M | 22.30M | 14.10M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 58.24M | 380.00K | -- | 50.26M | 377.00K |
| Repurchase of Common Stock | -- | -- | -476.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 58.24M | 380.00K | -476.00K | 50.26M | 377.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44.24M | -6.36M | 8.90M | 49.45M | -3.91M |